An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.
Experimental Treatment Acquiring Popularity Via Social Media
Retatrutide, which is still in clinical trials, is being advertised by online personalities for its supposed weight-reducing properties. Followers are encouraged to message these accounts directly for source information, while also obtaining discount codes.
Thriving Trade on Social Networks
Additionally, a flourishing trade exists on Telegram, where groups with thousands of participants share “before and after” images, injection guides and claims of rapid UK delivery. Sellers promote the drug there before directing buyers to other platforms for transactions.
Understanding Retatrutide
Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.
Healthcare Professionals Express Worries
However, physicians and chemists have cautions that the distribution of what remains an unlicensed medication in the UK is worrisome and could lead to individuals injecting products of uncertain source.
Several experts said the popularity for retatrutide could be linked to the rising price of approved weight loss treatments such as Mounjaro.
Regulatory Status and Enforcement
Marketing the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.
Some influencers attempt to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach pharmaceutical, marketing, and consumer regulations, potentially leading to fines, legal action or prison.
Service Reaction and Content Elimination
Based on the social media company, the service has taken down violative content and banned related hashtags and search suggestions. The company said it was committed to keeping the platform safe and investing in enhancing enforcement strategies.
Digital Marketplace Activities
Investigations also found groups with up to 9,000 members selling the experimental drug using Telegram's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” instantly displays channels with numerous of users, filled with photos of weight loss, glowing reviews and detailed guides for mixing or injecting at home.
After minutes of joining one group, a vendor shared contact information, where the majority of purchases occur. The seller provided an instruction manual and guaranteed delivery within two days. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one inquired about body mass, health issues or past usage.
Product Information and Costs
Within these communities, posts display black plastic packages with Royal Mail labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at home with sterile water, or ready-to-use injectors usually sold at £160 for 20 milligrams. When asked how much time a pen should be used, sellers give contradictory answers varying between a several days to “depends on your body”.
Platform Oversight and Security Measures
A spokesperson for Telegram stated it actively monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are injecting materials they can’t verify. Although the science behind retatrutide is sound, these digital versions may not contain what they claim,” stated Jason Murphy, the head of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor linked the increase in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit injections are highly risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she said.
Her staff has previously seen individuals harmed by self-injection from unverified sources. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.”
Producer Position
A representative from Eli Lilly said retatrutide was in third stage research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly investigational substance not yet approved … may expose users to potentially serious health risks”.
